• DRUM Magazine - 31 January 2013

The first new tuberculosis (TB) treatment in 50 years has recently been approved in the US and efforts are now being made to make it available in South African hospitals.

The new drug, bedaquiline, treats multidrug-resistant TB (MDR-TB) and costs less than the TB treatment currently available.

Bedaquiline is believed to shorten the treatment time of TB the full article

blog comments powered by Disqus


Related Media Coverage

“A TB drug that's been approved in the US could make it's way to SA, proving TB treatment cost effective and less time consuming”